Age at menarche is a complex trait and has a strong genetic component. This review summarizes the results of the genetic studies of age at menarche conducted to date, highlights existing problems in this area and outlines prospects of future studies on genetic factors for the trait.
Introduction
Menarche is the first menstrual bleeding that marks a beginning of the female's reproductive life. It is considered as one of the most important events in female puberty. There is a secular trend in the mean age at menarche with a steady decline over the last several decades (Hwang et al., 2003; Herman-Giddens, 2007) . Age at menarche has important implications in female fertility (McKibben and Poston, 2003; Pascual et al., 2005) and, furthermore, it may serve as an indicator of possible health complications in later life. Earlier menarche is associated with an increased risk of some diseases, such as breast cancer (Schatzkin et al., 1987; Peeters et al., 1995) , gynecological cancers (Marshall et al., 1998; Fujita et al., 2008) and various cardiovascular diseases (Cooper et al., 1999; Lakshman et al., 2009) . Girls with early menarche exhibited elevated blood pressure and glucose intolerance compared with girls who matured later (Remsberg et al., 2005) . Overall, earlier menarche (before 12 years) results in higher mortality (Lakshman et al., 2009) . On the other hand, there is a positive correlation between early menarche and high bone mineral density (Ito et al., 1995) . Recent data suggest that age at menarche is significantly associated with body composition, insulin sensitivity and blood lipid levels (Feng et al., 2008) .
Like many other complex traits, age at menarche is determined by both genetic and environmental factors and their interactions. The observed secular trend in age at menarche (Hwang et al., 2003; Herman-Giddens, 2007) may suggest that environmental rather than genetic factors are the major contributors to the observed phenotypic variance of the trait. However, this suggestion is inconclusive. Twin and familial studies of age at menarche indicated that 57 -82% of the variance in timing of puberty can be explained by heritable factors (Kaprio et al., 1995; Anderson et al., 2007; Morris et al., 2011) . Despite the fairly large range of the estimates, these data support the hypothesis that genetic factors play an important role in determining age at menarche. Among a wide variety of environmental factors that may contribute to age at menarche, weight, height, stressful life events, family relations, absence or presence of an adult male in the household, psychological adjustment (Graber et al., 1995) , nutrition, living standards (Graham et al., 1999) , physical activity (Chavarro et al., 2004) and ethnicity (Herman-Giddens et al., 1997; Anderson et al., 2003; Chumlea et al., 2003) were reported.
Identification of the environmental factors and genes that contribute to puberty and the timing of menarche may add to our understanding of the physiological mechanism of this trait and the associated fertility and health risks. In this paper, we review the current status of genetic studies conducted on age at menarche in humans. After providing an overview of the results of the genetic studies performed thus far, we aim to give recommendations for future studies to identify genetic factors involved in determining the variation in the timing of age at menarche.
Methods
The databases of MEDLINE (PubMed) and Google Scholar were searched electronically until May 2011 using the keywords: 'menarche', 'age at menarche' and 'puberty' in combination with the keywords 'polymorphism', 'candidate gene', 'genome-wide association study' and 'linkage'. All retrieved articles were screened for relevance to the topic of this manuscript following the HuGE guidelines (Bray et al., 2006; Ioannidis et al., 2008) . The reference lists of the retrieved articles were also screened for appropriate sources. Some of the retrieved articles, although formally matching some of the search keywords, did not contain data, that would be appropriate for the goals of our study. Therefore, such articles were excluded from the further analysis. The final set of the literature sources included all articles on genome-wide linkage mapping and genome-wide or candidate gene association studies of age at menarche (Fig. 1) .
Results
Our literature search yielded in total 35 articles on the genetics of age at menarche, including 4 articles on genome-wide linkage analysis, 6 papers on genome-wide association studies and 25 papers on association studies of various candidate genes.
Candidate gene association studies
Candidate genes related to estrogen metabolism
All genes mentioned in the article are described in Supplementary data, Table S1 . Since menarche is associated with significant changes in hormone levels, particularly estrogen (Sizonenko, 1989; Bandini et al., 2008) , genes involved in hormone metabolism were among the first candidates for analysis of their possible association with age at menarche. The first report about the association of estrogenmetabolizing genes with age at menarche was published in 1997, when the A1/A1 genotype of the common MspI polymorphism of the CYP17 gene was suggested to confer a later age at menarche (Feigelson et al., 1997) . The subsequent reports about a possible effect of this polymorphism on age at menarche were contradictory (Table I) . Finally, a meta-analysis of 11 case -control studies and 5 studies with continuous outcome and aggregate sample size of .11 000 individuals did not reveal any effect of this polymorphism on age at menarche (P . 0.05; Pei et al., 2008) .
Estrogen receptor a (ESR1) is a pleiotropic gene commonly studied for its association with various phenotypes. Two frequently analyzed polymorphisms of this gene are XbaI (rs9340799) and PvuII (rs2234693), which are in strong linkage disequilibrium. Except for a study by Stavrou et al. (2002) , all the others conducted so far reported no association of these single nucleotide polymorphisms (SNPs) with age at menarche (Table I) . However, one study (Manuck et al., 2011) suggested that the XbaI genotypes may affect age at menarche through interaction with the quality of family environment (P ¼ 0.007). Likewise, Stavrou et al. (2006) reported a combined effect of ESR1 and ESR2 on AAM. They also found that girls with the AA genotype of the ESR1 1730A G polymorphism had menarche a 7 months later than girls with the AG genotype (P ¼ 0.005).
The data on the possible association of other estrogen-metabolizing genes with age at menarche are scarce. Lai et al. (2001) analyzed the CYP3A4, CYP17, CYP1B1 and CYP1A2 genes in a multiethnic sample but found no association with age at menarche (Table I) . Three studies reported association of several SNPs and variable number of tandem repeats of the CYP19 gene with the onset of menarche (Guo et al., 2006b; Mitchell et al., 2008; Xita et al., 2010) . However, two of these studies (Mitchell et al., 2008; Xita et al., 2010) utilized very small samples, so that their results should be treated cautiously.
Finally, one study determined a significant association of the functional polymorphism (rs1042838, Val660Leu) of the progesterone receptor gene (PGR) with age at menarche (Taylor et al., 2010) . 
Continued

Miscellaneous genes
In addition to the estrogen-metabolizing genes, several genes involved in other metabolic processes were examined for their possible association with age at menarche (Table II) . Chemokine (C-C-motif) receptor 3 (CCR3), which plays an important role in metabolic pathways related to endometrial function (Zhang et al., 2000) , manifested significant association and linkage to age at menarche in a sample of 1048 Caucasian females from 354 nuclear families . This finding was later supported at the genome-wide level by the genome-wide association study, which also identified Sparc/Osteonectin, CWCV and Kazal-like domains proteoglycan (SPOCK) as a novel candidate gene for age at menarche (Liu et al., 2009) .
Obesity was previously reported as a factor influencing the onset of puberty (Matkovic et al., 1997; Lin-Su et al., 2002) , and serum leptin levels inversely correlated with age at menarche (Matkovic et al., 1997) . However, analyses of two leptin gene polymorphisms did not detect the association of the gene with the timing of menarche (Comings et al., 2001; Rothenbuhler et al., 2009;  Table II) . On the contrary, a replacement polymorphism (Q223R) of the leptin receptor gene (LEPR) was significantly associated with age at menarche (Riestra et al., 2011) .
Likewise, possible contribution to the age at menarche was recently suggested for two important pleiotropic genes, TNFRSF11A and TNFSF11 (also known as RANK and RANKL, respectively; Lu et al., 2010) . They have been acknowledged as key players in a wide variety of processes regulating cell death and proliferation, immunity, morphogenesis of the lymphoid tissue (Anderson et al., 1997; So et al., 2006) and, specifically, development of a lactating mammary gland during pregnancy (Theill et al., 2002) .
Some SNPs may not be associated with age at menarche directly but may influence it through SNP/SNP or/and SNP/environment interactions, as was recently reported for methylenetetrahydrofolate reductase (MTHFR), an important gene for homocysteine metabolism (Liu et al., 2010b) .
Genome-wide linkage analysis
Four genome-wide linkage analyses on age at menarche have been conducted to date (Table III) . Two studies (Guo et al., 2006a; Pan et al., 2008) were performed by the same research group on largely the same sample of about 2500 Caucasian females from .400 pedigrees, but the design of the studies was different. In Guo et al. (2006a) , a univariate linkage analysis was performed. In Pan et al. (2008) , a bivariate linkage analysis was conducted to identify loci that contribute to both age at menarche and bone mineral density. Both studies reported logarithms of the odd (LOD) . 3 for the same region, 22q13 (Table III) . This region was also identified by Rothenbuhler et al. (2006) although with lower LOD ¼ 1.09 -1.63. The region spans about 1 Mb and harbors nearly 50 genes, some of which may be candidates genes for age at menarche. The authors suggested two genes, E1A binding protein p300 (EP300) and sterol regulatory element-binding transcription factor-2 (SREBF2), as probable contributors to age at menarche (Guo et al., 2006a; Pan et al., 2008) . EP300 was shown to regulate interaction between steroidogenic factor-1 and early growth response-1 in their activating LH-b subunit gene, which is essential for differentiation of reproductive organs (Mouillet et al., 2004) . SREBF2 plays an important role in the transcription of sterolregulated genes and cholesterol homeostasis (Ettinger et al., 2004) . Interestingly, the microRNA miR33 located within intron 16 of the SREBF2 gene also participates in the control of cholesterol homeostasis (Najafi-Shoushtari et al., 2010) . This fact is in further support of the observed linkage of the 22q13 region with age at menarche.
A few more candidate genes for age at menarche were suggested in the other genomic regions identified by the studies of Guo et al. (2006a) and Pan et al. (2008) (Table III) . Catechol-O-methyltransferase (COMT) located on 22q11 is important for estrogen metabolism; PGR located on 11q23 is expressed in endometrium (Attia et al., 2000) and contributes to mammary gland morphogenesis (Brisken et al., 2000) . A candidate gene at 3p25 is peroxisome proliferator-activated receptor g (PPARG), which may influence the onset of menarche through modulation of estrogenic actions (Suzuki et al., 2006 Non-significant after correction for multiple testing.
Genetics of age at menarche (2006a) reported significant epistatic interaction between 22q13 and 3q13. Three linkage signals with LOD . 2 on chromosomes 8 and 16 (Table III) were reported by Rothenbuhler et al. (2006) who incorporated adjustment for menarcheal weight in their analysis. However, the sample size was much smaller, only 98 sister pairs.
In the largest genome-wide linkage study to date, three cohorts of Caucasian females from Australia, the UK and The Netherlands were combined in one large sample . Despite the large sample size and the large number of sibling pairs, the analysis of the combined sample did not identify genomic regions with significant (LOD . 3.0) linkage; only a peak with suggestive linkage (LOD ¼ 2.0) was determined on chromosome 12.
Genome-wide association studies
Despite the wide use of genome-wide association mapping in modern epidemiology, this approach was introduced to studies on genetics of age at menarche only in 2009, when results of four genome-wide association studies were published (He et al., 2009; Liu et al., 2009; Ong et al., 2009; Sulem et al., 2009) . Three of these studies (He et al., 2009; Ong et al., 2009; Sulem et al., 2009 ) reported a strong signal in the 6q21 region, where the LIN28B (lin-28 homolog B) gene is located (Table IV) . The LIN28B protein controls expression of mature miRNAs in the LET7 family (Viswanathan et al., 2009) . A major allele of this gene confers a 0.12 years earlier menarche ). In addition, LIN28B was associated with several other pubertal characteristics and height Widen et al., 2010) .
One of the recently identified important candidate genes for age at menarche is SPOCK (Liu et al., 2009) , which controls expression of MMP-2 (matrix metalloproteinase-2), a key gene involved in initiation of menstrual bleeding (Irwin et al., 1996; Nakada et al., 2001) . This study utilized a two-step design with genome-wide association studies at the first stage followed by candidate gene association and linkage mapping at the second stage.
One more candidate gene, transmembrane protein 38B (TMEM38B), was suggested based on the strong association signals for several SNPs located near this gene (He et al., 2009;  No direct association but three SNP/SNP interactions (rs2066470/rs1476413, rs2066470/rs4846049 and rs17037390/rs4846049).
There is not much information about the functions of this gene. However, experiments in animal models showed that this protein has two subtypes with complementary physiological functions related to intracellular Ca 2+ transport (Yazawa et al., 2007) .
Two other genome-wide association studies (Perry et al., 2009; Elks et al., 2010) confirmed the previously determined genes for age at menarche (LIN28B and TMEM38B) and identified 30 new loci with high statistical power (P , 5 × 10 28 ). In addition, 10 loci with suggestive association (P , 1.9 × 10 26 ) were determined. Both studies utilized a meta-analysis approach that made it possible to significantly increase the power of analysis. To date, the largest genome-wide association study of age at menarche by Elks et al. (2010) employed a two-stage design. At the first stage, a meta-analysis of 32 genome-wide association studies in 87 802 Caucasian women of European ancestry was performed, and then a follow-up replication association mapping in up to 14 731 women was conducted. The study by Elks et al. (2010) yielded other important results. It was previously suggested that age at menarche may have a shared genetic basis or correlate with some other complex traits, for example, obesity (Wang et al., 2006) , bone mineral density (Guo et al., 2005) and height (Onland-Moret et al., 2005) . Indeed, the Elks et al. (2010) study identified miscellaneous obesity candidate genes (e.g. FTO, SEC16B, TRA2B and TMEM18), bone metabolism genes (e.g. ESR1, BMP2 and BMP6), height-related genes (e.g. LIN28B, HMGA2 and PPARD) as associated with age at menarche. It also provided evidence that genes involved in energy homeostasis (BSX, CRTC1 and MCHR2) and hormonal regulation (INHBA, PCSK2 and RXRG) are also associated with age at menarche. Furthermore, using the ingenuity and gene-set enrichment pathway analyses, they suggested that co-enzyme A and fatty acid biosynthesis may be related to the onset of menarche.
One more SNP, rs13281615, significantly associated with age at menarche, was reported by a genome-wide association study of the breast cancer susceptibility loci in a cohort of 1002 Chinese females (Jiang et al., 2011) . This SNP is located on 8q24.21 with the closest annotated gene being POU class 5 homeobox 1B. However, this association might be a false-positive because the genome-wide significance was not high (P ¼ 0.023).
Discussion
Strengths, weaknesses, opportunities and threats
Although a strengths, weaknesses, opportunities and threats (SWOT) analysis has been commonly used mostly in business, examples of its successful application in biology and medicine are available (Garnick, 2007; Miller, 2007; Boytsov and van de Werf, 2011) . With respect to genetics of menarcheal age, the SWOT approach could help to evaluate current knowledge in this area and outline future efforts (Table V) . The strengths of this research area are largely outlined above, in Results. The main points of three other SWOT components are discussed below.
Problems in research on genetics of age at menarche
Owing to their importance for female health in later life, the research on the timing of onset of menarche and menopause has gained increased attention during the last decade. The number of published reports on genetics of these traits increases every year. A comprehensive review of the genetic studies on age at natural menopause was published recently (Voorhuis et al., 2010) . One of the main problems indicated in that review is inconsistency in results of different studies and failure to replicate previous findings. Only in a very few studies has association of the same polymorphisms or genomic regions with menopausal age been reported for different populations. Also, there is almost no overlap between results from the different types of study (i.e. candidate gene association studies, genome-wide linkage and genome-wide association analyses). The same issues may be applied to the studies on age at menarche, albeit to the lesser extent.
The inconsistency in the results of association studies may be caused by several factors. One of the most common of those is the different ethnic background of the studied populations (cohorts). It is an acknowledged fact that significant inter-ethnic differences exist in allele frequencies of many candidate genes for various complex traits (Beavan et al., 1998; Dvornyk et al., 2003; Lei et al., 2003) . These differences may underlie the well-known inter-ethnic dissimilarities in prevalence or characteristics of the traits, e.g. mean age at menarche (Herman-Giddens et al., 1997; Anderson et al., 2003; Chumlea et al., 2003 
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Continued cohort results in population stratification, which is common, for example, in the studies employing European Americans (Campbell et al., 2005) and may result in biased results (Marchini et al., 2004) . Another possible factor for the inconsistency is different sample size and therefore different statistical power of studies. Samples of some of the studies were quite small, i.e. ,200 individuals (Kulik-Rechberger et al., 2007; Mitchell et al., 2008; Xita et al., 2010) . Since complex traits are determined by many genes/polymorphisms, any single genetic variant contributes just a small proportion to the total variation of the trait. Therefore, small-scale studies may underestimate a real effect of polymorphisms (Ioannidis et al., 2003; Ambrosius et al., 2004; Hattersley and McCarthy, 2005) .
Differences in study design, for example, lack of control for covariates, may also cause the inconsistency of the results. Complex traits, such as age at menarche and age at natural menopause, are influenced by multiple environmental factors (Petridou et al., 1996; Chie et al., 1997; Dvornyk et al., 2006) , which may interact with candidate genes. The number of such environmental covariates is apparently large and many of them are still unknown, so that it is hardly possible to account for all of them. For that reason, an association analysis of complex traits always yields somewhat biased results. The bias may be quite noticeable if significant covariates were not incorporated into the analysis. Lack of control for at least the known significant covariates for age at menarche and age at natural menopause is often related to the fact that a great majority of published genetic studies on these traits were not specifically designed for this purpose but rather were a byproduct of epidemiological studies of other complex traits, for example, osteoporosis, cardiovascular diseases and cancers. It should be admitted, however, that the number of possible environmental covariates is apparently smaller for age at menarche than for age at natural menopause simply because of the fact that a life span before the former is much shorter than before the latter. Therefore, many factors with a potential significant effect may either not take place or have a much smaller effect during adolescence. For example, smoking, alcohol intake and duration of breastfeeding were determined among such significant factors for age at natural menopause (Lu et al., 2010 (Lu et al., , 2010a because of their estrogen-related effect (Harlow and Signorello, 2000; Ma et al., 2006) . However, they likely do not affect age at menarche because they usually occur in adulthood.
One more source for the inconsistency is a problem of multiple testing. It is thought that not adjusting for multiple testing may yield more false-positive results. On the other hand, strict adjustments for multiple testing (e.g. Bonferroni correction) are notoriously too conservative and in many cases reject the existing association, especially if it is weak, which is common for the candidate genes of complex traits. This problem is of particular concern in large-scale studies, for example, genome-wide association studies or genomewide gene expression profiling, when thousands of markers are analyzed simultaneously (Frazer et al., 2009) .
Some non-overlapping results of genome-wide linkage studies and genome-wide association studies may be attributed to differences in their concept and design. Linkage analysis is thought to be more appropriate for finding genes either contributing to monogenic traits or having 'a major gene effect' on a complex trait, i.e. accounting for a relatively large proportion to the overall genetic variance of the trait (Cui et al., 2010) . In contrast, the design of genome-wide association studies is usually based on the common gene: common disease hypothesis (Iyengar and Elston, 2007; Iles, 2008) .
The genome-wide linkage studies of age at menarche conducted so far by different groups of researchers yielded inconsistent results (Table I ). The possible reasons for that may lie in the complex genetic basis of age at menarche, between-study differences in design, sample size, statistical analyses used etc. Altogether, these factors affect the statistical power of the analysis, which is of key importance when considering the observed inconsistency between the studies . In most cases, the power of linkage analysis is low unless a locus/loci accounts for a substantial proportion of trait heritability (Risch and Merikangas, 1996) . For example, if a quantitative trait locus (QTL) has heritability of 10%, more that 800 000 random sib pairs should be analyzed to detect a linkage signal of LOD score 3.3 with 80% power at the significance level of 10 -4 (Risch and Merikangas, 1996) . Of course, such a sample size is far beyond that any linkage study can afford. Genetics of age at menarche
In addition to the above-mentioned inconsistency of results, there are two more gaps in genetic studies on menarcheal age: almost no results from ethnicities other than Caucasians and lack of genomewide gene expression profiling. Since age at menarche is a trait with some ethnic background (Herman-Giddens et al., 1997; Anderson et al., 2003; Chumlea et al., 2003) , genetic variants contributing to it may not be the same in different ethnicities (Jackson, 2004) .
It should be noted here that a weakness of focusing on menarche is that it is the arbitrary 'end-point' of an enormous cascade of events, called puberty. Therefore, a possibly limited contribution of genetic studies on menarche seen from the perspective of puberty must also be taken into account.
Menarcheal age and other complex traits: evidence for a shared genetic basis
The results of the genetic studies of age at menarche provide strong evidence for its shared genetic basis with many other traits, particularly those that are either associated with pubertal development (e.g. height, BMI, bone mineral density) or influenced by menarcheal age in later life (various disease phenotypes). For example, Elks et al. (2010) determined several obesity-and height-related genes to be associated with age at menarche (Supplementary data, Tables S2  and S3 ). Many genes were chosen for the association analysis based on the available information about the possible influence of age at menarche on the respective phenotypes. For example, estrogenmetabolizing genes, in addition to their well-known importance for reproductive function, have been extensively studied for their association with breast cancer (e.g. Andersen et al., 1994; Ye and Parry, 2002) and osteoporosis (see Liu et al., 2003 for review) . One of the reviewed articles provided direct evidence about two genomic regions (22q13 and 3p25), which may harbor a QTL for both age at menarche and bone mineral density (Pan et al., 2008) .
Another interesting question is whether the onsets of menarche and menopause are determined by the same genes. So far, attempts to determine correlations between these two phenotypes have yielded inconclusive results (e.g. Whelan et al., 1990; van Noord et al., 1997; Do et al., 1998; Peccei, 2000; Kaczmarek, 2007) . Estimates from a number of twin-and family-based studies suggest that the contribution of genetic factors to age at natural menopause is similar to that of age at menarche, i.e. 57 -82% (Snieder et al., 1998; de Bruin et al., 2001; Murabito et al., 2005) . The estrogendependent etiology of these traits suggests that genes involved in steroid metabolism may contribute to both. Indeed, results from genetic association studies suggest that at least some genes likely underlie both traits (e.g. Lu et al., 2010; Liu et al., 2010b) . On the other hand, the more pronounced secular trend of age at menarche may result from differences in gene -environment interactions. Currently, the data about these effects, as well as the combined effect of various genes (epistasis), on the timing of menarche are scarce. Therefore, putting more efforts into research on these effects will help to advance our knowledge about a genetic basis of menarcheal age.
Prospects for research on genetics of age at menarche
Significant modifications of the existing methodology for studies on genetics of age at menarche are needed to solve the problems outlined above. They can be summarized as follows.
Designs of the studies should be modified in order to increase their statistical power. This may include (but not be limited to) modifications commonly applied to population-and family-based association studies, genome-wide association studies, linkage studies and microarray expression profiling, such as increasing sample size, better controlling for various confounding factors, decreasing sample heterogeneity etc. (Risch and Merikangas, 1996; Hattersley and McCarthy, 2005; Lee and Saeed, 2007) . A powerful method is a meta-analysis, which makes it possible to significantly increase the sample size and the statistical power of analysis (Elks et al., 2010) . Another modification is shifting the research focus from the common gene: common disease hypothesis to the rare gene hypothesis (Frazer et al., 2009; Gorlov et al., 2011) . Rare variants (with population frequencies ,5%) were suggested to account for up to several percent of differences between phenotypes of carriers and noncarriers (Liu et al., 2005a) . However, genome-wide association studies and candidate gene association studies are not quite appropriate for detecting such rare variants because their methodology is grounded on the common variant hypothesis, as outlined above. To overcome these limitations, several approaches have been proposed recently (Bodmer and Bonilla, 2008; Zhang et al., 2010) .
Extensive studies on the ethnicities other than Caucasian are needed to elucidate a genetic basis of the inter-ethnic differences in age at menarche.
Microarrays are a very powerful method for genome-wide gene expression profiling and identification of genes, which may contribute to the given trait. Microarrays have been utilized extensively and efficiently for studying a genetic basis of various complex traits and diseases (e.g. Yanagawa et al., 2001; Arimoto et al., 2003; Liu et al., 2005b) , including menopause (Dvornyk et al., 2007; Gomez-Santos et al., 2011) . Although the studies on menopause were of a small scale and thus had limited power, they nonetheless demonstrated the feasibility of this approach and its appropriateness for the identification of candidate genes for this trait. Microarrays seem to be more suitable for searching for genes that underlie menarche/menopause per se rather than the timing of onset of these traits (Dvornyk et al., 2007) . On the other hand, a certain proportion of genes for menarche (or menopause) most likely contribute to the timing of these traits.
A real breakthrough in genetics of menarcheal age may be accomplished by implementing the systems approach, which incorporates candidate gene association studies, genome-wide association studies, linkage analysis, microarray gene expression profiling and proteomics in a single pipeline (Dvornyk et al., 2004) . This approach is based on a concept that the molecular mechanism underlying a trait consists of three regulatory levels, which correspond to DNA, mRNA and protein. Candidate QTL can be determined at each of these levels by using the respective methods: association and linkage, at the DNA level; genome-wide gene expression microarrays, at the mRNA level; and proteomics, at the protein level. Identification of the QTL for menarcheal age may follow either forward (DNA RNA protein) or backward (protein RNA DNA) strategies but the latter looks more promising because it provides a possibility for systemic analysis of the gene expression, respective regulatory networks, and effect of genegene and gene-environment interactions on the onset of a complex trait (Lei et al., 2005) . Ultimately, such a combined approach should open a new avenue in the efforts towards determining a genetic basis of menarche and its timing.
Several studies reviewed here have successfully demonstrated the power and efficiency of the systems approach by incorporating some of its elements. For example, identification of SPOCK as a candidate gene for age at menarche utilized genome-wide association studies and follow-up candidate SNP and haplotype-based association analysis (Liu et al., 2009) . Likewise, the design of the study, which replicated previous results on association of several candidate genes with menarcheal age and identified about 40 novel loci, incorporated a meta-analysis of several large-scale genome-wide association studies and the follow-up replication analysis (Elks et al., 2010) .
Threats
As age at menarche is a complex trait, the potential number of contributing genes may be very large. For example, a Skeletal Gene Database lists several hundred genes related to bone biology (Ho et al., 2000) . A task of identifying all candidate genes for a complex trait is therefore quite challenging, especially given that the effect of the most of them is quite weak. This is equally applicable to environmental factors. Another challenge is bringing the continuously growing volume of data (often controversial) from different studies to the common denominator, to make meaningful conclusions. Last but not least is to find out how to implement technically the results in order to accomplish a possible goal: managing age at menarche to prevent associated health complications later in life.
Conclusion
Research into the genetics of menarche and its timing is in its early stages. Despite great efforts having been made during the last decade and significant results obtained, the problem of determining the genetic factors underlying this trait is far from being solved. However, with the advances in modern high-throughput technologies and implementation of the systems approach, the ultimate goal of identifying genes and their variants contributing to menarche and its onset becomes achievable.
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